logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
B

Baek-Yeol Ryoo

Asan Medical Center
H指数:64
被引数:1.7万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Real-world outcomes of lenvatinib versus sorafenib as the second-line therapy after atezolizumab plus bevacizumab in patients with hepatocellular carcinoma: a large-scale multicenter study in Korea

仑伐替尼与索拉非尼作为阿替利珠单抗联合贝伐珠单抗后肝癌患者的二线治疗真实世界疗效：一项韩国大规模多中心研究

Hepatology International
IF6.1
2026-09-110
OAAI
Min Ji Lee; Subin Lim; Jae Yong Shim; Mi Na Kim; DongKyu Kim; Kyu‑pyo Kim; Kang Mo Kim; Baek‑Yeol Ryoo; Won‑Mook Choi; Hyun‑Jeong Kim; Seung‑Hoon Lee; Gaeun Kang; Mira Kang; Won Chul Cha; Jung Yong Hong; Woo Kyoung Jeong; Sung Kyung Ju; Jung‑Hyun Won; Doik Lee; Jiyoon Ahn; Do Young Kim
Real-World Comparison of Lenvatinib and Sorafenib as First-Line Treatments for Hepatocellular Carcinoma: A Multicenter Study

Lenvatinib和Sorafenib作为肝细胞癌一线治疗的真实世界比较：一项多中心研究

Journal of Hepatocellular Carcinoma
IF3.4
2025-11-250
OAAI
Mira Kang; Won Chul Cha; Dong Hyun Sinn; Woo Kyoung Jeong; Do Young Kim; Min Ji Lee; Subin Lim; DongKyu Kim; Kyu-Pyo Kim; Baek-Yeol Ryoo; Won-Mook Choi; Kang Mo Kim; Ki-Hun Kim; Doik Lee; Eui Jun Choi; Choungwon Jung; Joohyun Kim; Jung Yong Hong
Multicenter phase II trial of lenvatinib in patients with advanced hepatocellular carcinoma after progression on first-line atezolizumab plus bevacizumab

多中心II期临床试验，评估仑伐替尼在经一线阿替利珠单抗联合贝伐珠单抗治疗后进展的晚期肝细胞癌患者中的应用。

Journal of Hepatology
IF33
2025-09-040
OAAI
Hyung-Don Kim; Sun Jin Sym; Hong Jae Chon; Moonho Kim; Jung Hun Kang; Baek-Yeol Ryoo; Choong-kun Lee; Joohyun Hong; Hyewon Ryu; Woo Kyun Bae; Hyeyeong Kim; Hyunho Kim; Jin Won Kim; Tae-Yong Kim; Changhoon Yoo
Second-Line Fluoropyrimidine-Based Chemotherapy in Advanced Biliary Tract Cancer: A Meta-analysis Based on Individual Patient-Level Data of Randomized Trials

二线以氟嘧啶为基础的化疗在晚期胆道癌中的应用：一项基于随机试验个体患者数据的Meta分析

CANCER RESEARCH AND TREATMENT
IF3.8
2024-10-170
OA
Hyung, Jaewon; Kang, Minsu; Kim, Ilhwan; Kim, Kyu-pyo; Ryoo, Baek-Yeol; Cheon, Jaekyung; Ryu, Hyewon; Lee, Ji Sung; Kim, Ji-Won; Choi, In Sil; Park, Jin Hyun; Abou-Alfa, Ghassan K.; Kim, Jin Won; Yoo, Changhoon
Impact of Etiology on Efficacy Outcomes with Atezolizumab Plus Bevacizumab in Patients with Advanced Hepatocellular Carcinoma: A Multinational Retrospective Analysis in Asia-Pacific

病因学对晚期肝细胞癌患者阿特珠单抗联合贝伐单抗疗效结局的影响: 亚太地区的跨国回顾性分析

TARGETED ONCOLOGY
IF4
2024-10-030
PRE
Kim, Sejin; Lee, Suat Ying; Cheon, Jaekyung; Kim, Hyung-Don; Park, Young Gyu; Lee, Joycelyn Jie Xin; Ryu, Min-Hee; Ryoo, Baek-Yeol; Tai, David; Yoo, Changhoon
Artificial Intelligence-Powered Spatial Analysis of Tumor-Infiltrating Lymphocytes as a Potential Biomarker for Immune Checkpoint Inhibitors in Patients with Biliary Tract Cancer
CLINICAL CANCER RESEARCH
IF10.2
2024-08-161
PRE
Bang, Yeong Hak; Lee, Choong-kun; Bang, Kyunghye; Kim, Hyung-Don; Kim, Kyu-pyo; Jeong, Jae Ho; Park, Inkeun; Ryoo, Baek-Yeol; Lee, Dong Ki; Choi, Hye Jin; Chung, Taek; Jeon, Seung Hyuck; Shin, Eui-Cheol; Oum, Chiyoon; Kim, Seulki; Lim, Yoojoo; Park, Gahee; Ahn, Chang Ho; Lee, Taebum; Finn, Richard S.; Ock, Chan-Young; Shin, Jinho; Yoo, Changhoon
Cabozantinib plus atezolizumab versus sorafenib for advanced hepatocellular carcinoma (COSMIC-312): final results of a randomised phase 3 study

卡博替尼联合阿特珠单抗与索拉非尼治疗晚期肝细胞癌 (COSMIC-312): 一项随机3期研究的最终结果

LANCET GASTROENTEROLOGY & HEPATOLOGY
IF38.6
2024-04-0119
PRE
Yau, Thomas; Kaseb, Ahmed; Cheng, Ann-Lii; Qin, Shukui; Zhu, Andrew X.; Chan, Stephen L.; Melkadze, Tamar; Sukeepaisarnjaroen, Wattana; Breder, Valery; Verset, Gontran; Gane, Edward; Borbath, Ivan; Rangel, Jose David Gomez; Ryoo, Baek-Yeol; Makharadze, Tamta; Merle, Philippe; Benzaghou, Fawzi; Milwee, Steven; Wang, Zhong; Curran, Dominic; Kelley, Robin Kate; Rimassa, Lorenza
Regorafenib plus nivolumab in unresectable hepatocellular carcinoma: the phase 2 RENOBATE trial

Regorafenib联合nivolumab治疗不可切除的肝细胞癌: 2期RENOBATE试验

NATURE MEDICINE
IF50
2024-02-1914
OAAI
Kim, Hyung-Don; Jung, Seyoung; Lim, Ho Yeong; Ryoo, Baek-Yeol; Ryu, Min-Hee; Chuah, Samuel; Chon, Hong Jae; Kang, Beodeul; Hong, Jung Yong; Lee, Han Chu; Moon, Deok-Bog; Kim, Ki-Hun; Kim, Tae Won; Tai, David; Chew, Valerie; Lee, Jeong Seok; Finn, Richard S.; Koh, June-Young; Yoo, Changhoon

研究方向

暂未获取到该数据
C
Changhoon Yoo
H 指数:45论文数:463被引数:9,174
M
Min‐Hee Ryu
H 指数:60论文数:522被引数:2.0万
Y
Yoon‐Koo Kang
H 指数:93论文数:864被引数:6.0万
K
Kyu‐pyo Kim
H 指数:40论文数:302被引数:5,730
J
Jae Ho Jeong
H 指数:25论文数:251被引数:2,427
H
Heung-Moon Chang
H 指数:29论文数:142被引数:2,993
S
Sook Ryun Park
H 指数:38论文数:210被引数:7,178
H
Ho Yeong Lim
H 指数:78论文数:586被引数:3.9万
M
Masatoshi Kudo
H 指数:143论文数:2,840被引数:12.5万
K
Kang Mo Kim
H 指数:50论文数:273被引数:9,831